Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Koliarne Tong"'
Autor:
Koliarne Tong, Claire E. Wainwright, Peter G. Middleton, Hugh Greville, Douglas J. Dorahy, Daniel Barker, Peter A. B. Wark, Lucy D. Burr, Simone K. Visser
Publikováno v:
Journal of Cystic Fibrosis. 19:415-420
Lumacaftor/ivacaftor (LUM/IVA) improves outcomes in cystic fibrosis (CF) patients homozygous for Phe508del with ppFEV140%. There is limited safety or efficacy data in patients with ppFEV140%. We determined whether LUM/IVA in patients with ppFEV140 wo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aab5285e3bcf4c447ade4c177183c2c3
https://doi.org/10.1016/j.jcf.2019.12.006
https://doi.org/10.1016/j.jcf.2019.12.006
Autor:
Koliarne Tong, Douglas Dorahy, Megan France, Lucy Burr, Hugh Greville, Simone Visser, Peter Middleton, Claire Wainwright, Daniel Barker, Peter Wark
Publikováno v:
Cystic fibrosis.
Background: Lumacaftor/ivacaftor (LUM/IVA) has been shown to improve percent predicted FEV1 (ppFEV1) and reduce exacerbation frequency in patients with ppFEV1 40 – 90. However, there is limited safety or efficacy data on its use in patients with pp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f94cbfc1df71e5a8623cf5c1ff558a4e
https://doi.org/10.1183/13993003.congress-2019.oa2126
https://doi.org/10.1183/13993003.congress-2019.oa2126
